Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate Antagonist

Biological Psychiatry

Volumn 65, Issue 2, 2009, Pages 181-184

  Phelps, Laura E ^a   Brutsche, Nancy ^a   Moral, Jazmin R ^a   Luckenbaugh, David A ^a   Manji, Husseini K ^a   Zarate Jr , Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Alcohol dependence; depression; family history; glutamate; ketamine; NMDA receptor

Indexed keywords

ANTIDEPRESSANT AGENT; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; AGED; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; EXCITATORY AMINO ACID ANTAGONISTS; FAMILY; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KETAMINE; LINEAR MODELS; MALE; MIDDLE AGED; PEDIGREE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58049211903     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.09.029     Document Type: Article

References (21)

1. Davis L.L., Frazier E.C., Gaynes B.N., Trivedi M.H., Wisniewski S.R., Fava M., et al. Are depressed outpatients with and without a family history of substance use disorder different?. A baseline analysis of the STAR*D cohort. J Clin Psychiatry 68 (2007) 1931-1938
2. Preisig M., Fenton B.T., Stevens D.E., and Merikangas K.R. Familial relationship between mood disorders and alcoholism. Compr Psychiatry 42 (2001) 87-95
3. Davis L.L., Frazier E., Husain M.M., Warden D., Trivedi M., Fava M., et al. Substance use disorder comorbidity in major depressive disorder: A confirmatory analysis of the STAR*D cohort. Am J Addict 15 (2006) 278-285
4. Sanacora G., Rothman D.L., Mason G., and Krystal J.H. Clinical studies implementing glutamate neurotransmission in mood disorders. Ann N Y Acad Sci 1003 (2003) 292-308
5. Maeng S., Zarate Jr. C.A., Du J., Schloesser R.J., McCammon J., Chen G., et al. Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63 (2008) 349-352
6. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47 (2000) 351-354
7. Zarate Jr. C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63 (2006) 856-864
8. Tsai G., Gastfriend D.R., and Coyle J.T. The glutamatergic basis of human alcoholism. Am J Psychiatry 152 (1995) 332-340
9. Krystal J.H., Petrakis I.L., Krupitsky E., Schutz C., Trevisan L., and D'Souza D.C. NMDA receptor antagonism and the ethanol intoxication signal: From alcoholism risk to pharmacotherapy. Ann N Y Acad Sci 1003 (2003) 176-184
10. Pomarol-Clotet E., Honey G.D., Murray G.K., Corlett P.R., Absalom A.R., Lee M., et al. Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry 189 (2006) 173-179
11. Petrakis I.L., Limoncelli D., Gueorguieva R., Jatlow P., Boutros N.N., Trevisan L., et al. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry 161 (2004) 1776-1782
12. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
14. Beck A.T., and Beamesderfer A. Assessment of depression: The depression inventory. Mod Probl Pharmacopsychiatry 7 (1974) 151-169
15. Bremner J.D., Krystal J.H., Putnam F.W., Southwick S.M., Marmar C., Charney D.S., et al. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress 11 (1998) 125-136
16. Overall J.E., and Gorham D.R. The Brief Psychiatric Rating Scale. Psychol Rep 10 (1962) 799-812
17. Maxwell M.E. Family Interview for Genetic Studies (FIGS): A Manual for FIGS (1992), Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD
18. Braitman L.E., and Rosenbaum P.R. Rare outcomes, common treatments: Analytic strategies using propensity scores. Ann Intern Med 137 (2002) 693-695
19. Schumann G., Johann M., Frank J., Preuss U., Dahmen N., Laucht M., et al. Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch Gen Psychiatry 65 (2008) 826-838
20. Boyce-Rustay J.M., and Holmes A. Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit. Psychopharmacology (Berl) 187 (2006) 455-466
21. Petrenko A.B., Yamakura T., Fujiwara N., Askalany A.R., Baba H., and Sakimura K. Reduced sensitivity to ketamine and pentobarbital in mice lacking the N-methyl-D-aspartate receptor GluRepsilon1 subunit. Anesth Analg 99 (2004) 1136-1140